Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.32 USD | -0.17% | -4.31% | -32.13% |
May. 22 | CONMED Keeps Quarterly Dividend at $0.20 a Share, Payable July 5 to Shareholders of Record June 14 | MT |
May. 22 | CONMED Corporation Declares Quarterly Cash Dividend, Payable on July 5, 2024 | CI |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-32.13% | 2.29B | B- | ||
-3.87% | 184B | C+ | ||
-0.52% | 107B | C | ||
-3.65% | 67.9B | A | ||
-5.79% | 46.49B | B- | ||
+13.26% | 45.81B | B- | ||
+6.38% | 42.55B | B+ | ||
+18.83% | 30.78B | B | ||
+16.53% | 26.11B | A- | ||
-6.80% | 23.9B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CNMD Stock
- Ratings CONMED Corporation